Items where Author is "Moghadasi, A. N."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 31.

Article

(2025) Computerized cognitive rehabilitation in patients with multiple sclerosis (MS): A systematic review and meta-analysis. Caspian Journal of Internal Medicine. pp. 9-19. ISSN 2008-6164

(2025) Investigating treatment alternatives for fingolimod in patients with multiple sclerosis developed refractory fingolimod-related genital Human Papilloma Virus (HPV) infection. Multiple Sclerosis and Related Disorders. p. 5. ISSN 2211-0348

(2024) Evaluating efficacy and safety of ocrelizumab biosimilar (Xacrel) compared to the originator (Ocrevus) in relapsing multiple sclerosis: a phase III, randomized, equivalency, clinical trial. Scientific Reports. p. 12. ISSN 2045-2322

(2024) Time interval between the onset of symptoms and diagnosis of multiple sclerosis and the influential factors: A national registry-based study. Clinical Neurology and Neurosurgery. p. 7. ISSN 0303-8467

(2024) A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic. Journal of Neurology. p. 12. ISSN 0340-5354

(2024) The prevalence of multiple sclerosis (MS) in Oceania, a systematic review, and meta-analysis. Neurological Sciences. pp. 75-82. ISSN 15901874 (ISSN)

(2023) Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review. Current Journal of Neurology. pp. 110-114. ISSN 2717-011X

(2023) Economic and Social Standing of Individuals in Iran Diagnosed with Multiple Sclerosis. Archives of Iranian Medicine. pp. 413-418. ISSN 1029-2977

(2023) Evaluating the Influential Factors on the Time Interval between the Symptoms Onset and Diagnosis of Patients with Multiple Sclerosis. Multiple Sclerosis Journal. pp. 715-716. ISSN 1352-4585

(2023) Fear of re-infection, relapse, and anxiety during COVID-19 pandemic in patients with multiple sclerosis: A multi-center study. Current Journal of Neurology. pp. 82-86. ISSN 2717-011X

(2023) Iranian specialists' approach to surgery in patients with multiple sclerosis. Current Journal of Neurology. pp. 96-102. ISSN 2717-011X

(2023) Iranian specialists' approach to treatment escalation in multiple sclerosis patients with cognitive impairment Accepted. Current Journal of Neurology. pp. 1-7. ISSN 2717-011X

(2023) Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics. Multiple Sclerosis and Related Disorders. p. 5. ISSN 2211-0348

(2023) Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter Study. Archives of Iranian Medicine. pp. 647-653. ISSN 1029-2977

(2023) The relationship between retinal layer thickness and cognition in patients with multiple sclerosis: A systematic review of current literature. Current Journal of Neurology. pp. 50-57. ISSN 2717-011X

(2022) 18FFDG brain PET and clinical symptoms in different autoantibodies of autoimmune encephalitis: a systematic review. NEUROLOGICAL SCIENCES. pp. 4701-4718. ISSN 1590-1874 1590-3478 J9 - NEUROL SCI

(2022) Artificial intelligence in the diagnosis of multiple sclerosis: A systematic review. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Characteristics of COVID-19 in patients with multiple sclerosis. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Epidemiology of familial multiple sclerosis in Iran: a national registry-based study. BMC NEUROLOGY. ISSN 1471-2377 J9 - BMC NEUROL

(2022) Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Socioeconomic status of Iranian patients with multiple sclerosis in relation to disease-induced disability. Multiple Sclerosis Journal. p. 935. ISSN 1352-4585

(2021) Pregnancy outcome in patients with multiple sclerosis treated with Rituximab: A case-series study. Multiple Sclerosis and Related Disorders. ISSN 2211-0348

(2021) Pregnancy outcome in patients with neuromyelitis optica spectrum disorder treated with rituximab: A case-series study. CASPIAN JOURNAL OF INTERNAL MEDICINE. S491-S494. ISSN 2008-6164 2008-6172 J9 - CASP J INTERN MED

(2021) YY Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study. Caspian Journal of Internal Medicine. pp. 263-274. ISSN 2008-6164

(2021) The contribution of self-disclosure to the prediction of mood symptoms in patients with multiple sclerosis. CURRENT JOURNAL OF NEUROLOGY. pp. 214-221. ISSN 2717-011X J9 - CURR J NEUROL

(2021) The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis. Neurol Sci. pp. 1-7. ISSN 1590-1874 (Print) 1590-1874

(2021) The prevalence of cognitive impairment in patients with neuromyelitis optica spectrum disorders (NMOSD): A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. ISSN 2211-0348

(2019) Management of seizures in patients with multiple sclerosis; an Iranian consensus. Epilepsy & Behavior. ISSN 1525-5069 (Electronic) 1525-5050 (Linking)

(2019) Multiple sclerosis national registry system in Iran: Validity and reliability of a minimum data set. Multiple Sclerosis and Related Disorders. pp. 158-161. ISSN 2211-0348

(2017) Catastrophic presentation of a patient with combined NMOSD and thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a case report. Acta Neurologica Belgica. pp. 757-759. ISSN 0300-9009

(2017) Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations. Multiple Sclerosis and Related Disorders. pp. 144-151. ISSN 2211-0348

This list was generated on Thu May 8 19:25:58 2025 +0330.